Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Kuros Biosciences announces enrollment of first patient in ASTRA study – A…
Kuros Biosciences announces enrollment of first patient in ASTRA study –A global, prospective, randomized, multi-center clinical trial in foot and ankle fusionSchlieren (Zürich), Switzerland, December 2, 2025– Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, today announced that the first patient has been enrolled in its global ASTRA (Ankle Subtalar arThrodesis Randomized Assessment) study. ASTRA is a prospective, randomized,...
Nasdaq GlobeNewswire
02/12/2025
Roche receives FDA clearance with CLIA waiver and CE Mark for its first…
The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to act quickly and prevent severe complications and onward transmission.Detects and differentiates between three types of Bordetella infection that can cause similar cough symptoms, ensuring patients receive the right diagnosis at the earliest opportunity.Early diagnosis can reduce the risk of complications and severe disease in vulnerable groups such as infants and the elderly, by...
Nasdaq GlobeNewswire
02/12/2025
Colorectal Cancer Market Set to Expand Throughout Forecast Period (2025-2034)…
Colorectal Cancer Market Summary Colorectal Cancer Market Summary Discover the colorectal cancer new treatment @New Treatments for Colorectal Cancer Key Factors Driving the Growth of the Colorectal Cancer Market Increasing Colorectal Cancer Incidence The growing global incidence of colorectal cancer is a primary market driver, attributed to aging populations, lifestyle changes, and rising risk factors such as obesity, sedentary habits, diets high in processed meats,...
PR Newswire
01/12/2025
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial…
Company AnnouncementCOPENHAGEN, Denmark; December 1, 2025 –Genmab A/S(Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
01/12/2025
/C O R R E C T I O N -- Crisis Prevention Institute/
"Andee's appointment marks the beginning of an exciting new chapter for CPI," said Adam Reinmann and Harper Mates, Managing Directors with Wendel, and members of CPI's Board of Directors. "Her career reflects a dedication to empowering organizations and people, through innovation, digital transformation, and culture building–aligning directly with CPI's mission. We are deeply grateful for Tony Jace's remarkable leadership over the past 16 years. His vision and commitment have…
PR Newswire
01/12/2025
CQ Medical® Expands Radiation Therapy Portfolio With Bionix Business Unit…
CQ Medical was formed in 2022 through the combination of CIVCO Radiotherapy and Qfix, bringing together decades of expertise in advanced radiation therapy positioning and immobilization solutions. The CQ Medical portfolio covers a range of clinical applications, including devices for precision stereotactic treatment and proton therapy, implantable fiducial markers for image-guided radiotherapy, customizable thermoplastic patient immobilization, and patient transfer systems for radiotherapy and…
PR Newswire
01/12/2025
EssilorLuxottica creates Scientific Advisory Committee to accelerate the next…
EssilorLuxottica creates Scientific Advisory Committeeto accelerate the next era of innovationParis, France (1 December 2025)– EssilorLuxottica announced the creation of its Scientific Advisory Committee, bringing together some of the world’s most sought-after scientists and thought leaders from the converging fields of science, technology and healthcare. This initiative will reinforce the Group’s enduring scientific foundation and its mission to empower patients and consumers...
Nasdaq GlobeNewswire
01/12/2025
Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars…
Rising healthcare expenditure in key economies, increasing pressure to deliver value-based treatment pathways, and an expanding patient base are all pushing biologics and biosimilars into the mainstream. These therapies are no longer exclusive to advanced hospital systems. Broader regulatory support, strengthened manufacturing capabilities, and strategic investments from major pharmaceutical companies have collectively expanded market accessibility. As chronic diseases become more complex and…
PR Newswire
01/12/2025
Medical Adhesive Tapes Market Surges to USD 5.8 Billion by 2033, Propelled by…
Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=79213&utm_source=PRNewswire&utm_medium=360 Browse in-depth TOC on Medical Adhesive Tapes Market 202 - Pages 126 – Tables 37 – Figures Scope of The Medical Adhesive Tapes Market Report Global Medical Adhesive Tapes Market Overview Medical Adhesive Tapes Market: Trends and Opportunities Executive Market Analysis Market leaders and...
PR Newswire
01/12/2025
Cystic Fibrosis Therapeutics Market Set to Reach USD 35.09 Billion by 2033 as…
Cystic fibrosis, a life-long autosomal recessive disorder caused by mutations in the CFTR gene, affects more than 162,000 patients globally, with rising diagnostic rates enabling broader therapeutic adoption. The past five years have shifted the market from symptomatic management to disease-modifying treatments, marking the most significant clinical progress in CF care in decades. Cystic fibrosis, a life-long autosomal recessive disorder caused by mutations in the CFTR gene, affects more than...
PR Newswire
01/12/2025
IVD Labware Market worth $5.04 billion by 2030 with 6.0% CAGR |…
Browse in-depth TOC on "IVD Labware Market" Browse in-depth TOC on "IVD Labware Market" 523 - Tables55 - Figures392 - Pages By application,the IVD labware market is segmented into immunoassays, clinical chemistry, molecular diagnostics, hematology, microbiology, and other applications. In 2024, the clinical chemistry segment accounted for the largest share of the IVD labware market because it supports some of the highest-volume tests performed across diagnostic...
PR Newswire
01/12/2025
OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class…
Preclinical data to be presented by Dr. Gastón Soria, Co-Founder and Chief Scientific Officer, will highlight: Preclinical data to be presented by Dr. Gastón Soria, Co-Founder and Chief Scientific Officer, will highlight: "The selection of ONC001 for an oral presentation at ASH underscores the strength of this fundamentally new therapeutic approach," saidTarek Zaki, Co-Founder & Chief Executive Officer of OncoPrecision. "ONC001 is designed to specifically target resistance…
PR Newswire
01/12/2025
Respiratory Syncytial Virus Market to Reach USD 4.54 Billion by 2033 as Global…
Download PDF Brochure: https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-market Browse in-depth TOC on "Respiratory Syncytial Virus (RSV) Market" 62 – Tables 57 – Figures 159 – Pages A New Vaccination Era: Why the RSV Market Is Scaling Faster Than Ever Before In the past two years, RSV has shifted from being an overlooked seasonal virus...
PR Newswire
01/12/2025
Dubai Wellness Franchise elegant hoopoe Brings AI-Powered Model to UK as…
The global franchise industry surpassed $890 billion in 2024, yet legacy models struggle to adapt to post-COVID consumer behaviour, rising regulatory complexity and structural inefficiency. Meanwhile, the wellness economy has exceeded $1.5 trillion, with UK consumers increasingly demanding evidence-based, outcomes-driven longevity care. AI-enabled franchises - built on accuracy, adaptability and transparent performance - are rapidly outperforming traditional networks. The global franchise...
PR Newswire
01/12/2025
The Frost & Sullivan Institute Honors Global Organizations Pioneering…
The award selection framework follows a rigorous eight-step evaluation process conducted in collaboration with Frost & Sullivan's global think tank. Companies are then reviewed for leadership best practices, benchmarked on innovation and sustainability metrics, and vetted through multiple independent perspectives. The award selection framework follows a rigorous eight-step evaluation process conducted in collaboration with Frost & Sullivan's global think tank. Companies are then…
PR Newswire
01/12/2025
Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10…
Giovanni Di Napoli, Chief Executive Officer of Cosmo, commented, "This approval reflects the strength of our collaboration with Glenmark and our shared commitment to advancing dermatologic care. Winlevi represents a first-in-class topical innovation that redefines how acne is treated, and we are excited to see it become accessible to patients throughout Europe." Giovanni Di Napoli, Chief Executive Officer of Cosmo, commented,"This approval reflects the strength of our…
PR Newswire
01/12/2025
Akura Medical, a Shifamed Portfolio Company, Closes $53 Million in Series C…
"Akura Medical is advancing a differentiated portfolio of venous thrombectomy technologies aimed at improving procedural precision and patient outcomes. The recent introduction of our NavIQ quantification software represents the next step toward intelligent, data-driven thrombectomy," said Amr Salahieh, Chair and Acting Chief Executive Officer, Akura Medical. "This new capital enables us to accelerate product development and continue building the foundation for long-term growth…
PR Newswire
01/12/2025
SmartSkin Launches Pharma Seal Assurance Solution to Deliver Real-Time Insights…
SmartSkin Seal Assurance provides per-head, real-time feedback on sealing performance by measuring and visualizing forces during capping. Each event generates a digital signature, creating auditable proof that every capper head is configured and operating within specification. This record helps confirm setup quality and consistency. Compatible with single and multi-head systems, it complements Residual Seal Force (RSF) testing by confirming that sealing conditions measured in RSF are...
PR Newswire
01/12/2025
Philips expands commercial availability of world’s first real-time AI-enabled…
Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA –Royal Philips(NYSE: PHG, AEX: PHIA,a global leader in...
Nasdaq GlobeNewswire
01/12/2025
MediView Achieves First CE Mark, Bringing Augmented Reality to European…
The line between the physical and digital world has been blurred, equipping clinicians with the information they need at the point of care to make the best decisions for patients. This transformative imaging technology is being leveraged as an alternative to traditional, cumbersome 2D imaging solutions by giving physicians the ability to improve workflow efficiency, ergonomics, and 3D visualization, while unlocking new levels of spatial awareness and real-time data access. MediView's system uses…
PR Newswire
01/12/2025
ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau…
Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS’ PRECISE-AD trialProMIS on track to leverage new plasma pTau insights with planned Q2 2026 interim readout Cambridge, Massachusetts, Dec.01, 2025(GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic...
Nasdaq GlobeNewswire
01/12/2025
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring…
This partnership combines Dyadic’s innovation capabilities with BRIG BIO’s expertise in dairy and medical nutrition, with the goal of advancing scalable, cost-effective production of animal-free alpha-lactalbumin for early life, active, healthy aging, and medical nutrition markets. Together, the companies aim to accelerate commercialization timelines, support commercially viable production, enhance market affordability, and expand global access to sustainable proteins with comparable...
Nasdaq GlobeNewswire
01/12/2025
ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare…
thAnnual Evercore Healthcare Conference on Tuesday, December 2nd, 2025.The fireside chat will be held at 3:25pm Eastern Time and a live webcast of the presentation may be accessed by visiting the Events page of the Company’s website at www.promisneurosciences.com . The webcast will be available for at least 30 days following the event. About ProMIS Neurosciences Inc. ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of...
Nasdaq GlobeNewswire
01/12/2025
Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing…
Financing co-led by NovaCapital, private high-net-worth individuals and members of Club Degli Investitori “We are thrilled to have the support of a diverse investor base who believe strongly in the promise that radiopharmaceuticals offer to the future of patient care.” said Alex Agnoletto, CEO. “Our founding team brings deep expertise within global radiopharmaceutical development and manufacturing and is well positioned to advance our pipeline to address patient needs.” About Juniper...
Nasdaq GlobeNewswire
01/12/2025
Altri Comunicati
